Ultima Genomics

Gene sequencing company aiming to reduce the cost of sequencing a human genome to $100 using novel high-throughput sequencing technology. Raised approximately $600 million in venture capital.

Location
Fremont, California, USA
Founded
2016
Investors
8
Categories
genomics-sequencing, biotech, life-sciences-tools

Notes

Ultima Genomics is a gene sequencing company focused on dramatically reducing the cost of genome sequencing. The company is headquartered in Fremont, California.

Ultima exited stealth mode in June 2022 with approximately $600 million in venture capital funding and an ambitious goal: to reduce the cost of sequencing a human genome to $100. The company's novel sequencing approach uses a flow-based technology that differs from existing sequencing platforms.

Key innovations include:

  • Novel sequencing chemistry
  • High-throughput flow cell design
  • Cost-efficient reagent consumption
  • Scalable architecture

The $100 genome would represent a significant milestone in making genomic sequencing accessible for routine clinical use.

Team

Additional Research Findings

  • Raised approximately $600 million in venture capital (June 2022)
  • Investors: General Atlantic, Andreessen Horowitz, D1 Capital, Khosla Ventures, Lightspeed Venture Partners, aMoon, Playground Global, Founders Fund
  • $100 genome goal
  • High-throughput sequencing technology
  • Fremont, California headquarters
  • Founded in 2016

Sources

Investors

NameLocationTypeStagesPortfolio
Andreessen Horowitz (a16z)Menlo Park, USAgeneralist
seedseries-a+3
1
Khosla VenturesMenlo Park, California, USAgeneralist
seedseries-a+3
2
General AtlanticNew York, New York, USApe
growth
1
D1 Capital PartnersNew York, USAgeneralist
series-cgrowth
1
Lightspeed Venture PartnersMenlo Park, California, USAgeneralist
seedseries-a+3
3
aMoonTel Aviv, Israelbiotech-focused
series-aseries-b+2
8
Playground Global-generic-1
Founders FundSan Francisco, California, USAgeneralist
seedseries-a+3
1